*In the N-CPAP group, patients were randomized either to conservative management (Cons) or treatment with N-CPAP. Patieilts selected for surgical treatment were randomized either to conservative management (Cons) or surgery (UPPP with or without mandibular osteotomy). 'VAS=visual analog scale: 0=none; 100=very severe. therapeutic role of nasal CPAP as well as that of operative treatment (UPPP with or without mandibular osteotomy) in comparison to conservative management in patients with OSAS.
MATERIALS AND METHODS

Patients
Mental or physical effects were required for a diagnosis of OSAS in addition to a diagn-ostic finding in an overnight polygraphic recording (the number ofoxygen desaturations -4% or 10% per hour of time spent in bed) and a "periodic breathing" pattern in both static-charge-sensitixve bed and thermistor channels. Results 
RESULTS
Of the 21 patients randomized to treatment with N-CPAP, 6 were not willing to continue CPAP after the first night because of failure to adjust to the machine. Two further patients discontinued CPAP treatment due to nasal problems. These eight patients had no uniform findings as regards severity of disease or other characteristics.
Based on intention to treat, compliance with CPAP at 1 year was 62% (13/21). For those patients who continued therapy after the initial hospital nights, the compliance rate was 87% (13/15) . Compliant patients used the machine a minimum of 5 nights a week and a minimum of 4 h a night. This information was based on the machine's built-in counter combined with selfreports. The median pressure required was 10 cm H20 (range, 7.5 to 18.5). The 13 patients who used N-CPAP regularly reported the following side effects: rhinorrhea
Of the 32 patients, who fulfilled the criteria for surgery, 18 were randomized to surgery and 14 to conservative treatment. For 13 patients, UPPP alone was performed, whereas 5 patients underwent both UPPP and mandibular osteotomy.
All postoperative complications following UPPP were minor: 2 of the 13 patients experienced velopharyngeal insufficiency. Ofthe 5 patients in whom UPPP and mandibular osteotomy were performed, 1 had a tracheotomy for 1 month postoperatively and 2 had reoperations for removal of infected material. The overall complication rate was 22% (4/18).
Cardiovascular Mortality and Morbidity
A 58-year-old man considered to be a candidate for N-CPAP and randomized to conservative management died during the study period. The immediate cause of his death was cardiac arrest, confirmed at autopsy. Another patient randomized to conservative management in the CPAP group experienced a transient ischemic cerebral attack. None of the patients receiving N-CPAP experienced any cardiovascular complications. During the study period, among the patients who had undergone surgery, one non-Q myocardial infarction and one transient ischemic cerebral attack occurred.
Overnight Polygraphic Recordings
All of the 12 CPAP patients and 1 of the corresponding control group had a normal OD14 (' 10) at 1 year (p<0.001) ( Table 2 ). Seven of the surgical patients and 1 of their control subjects had a normal OD14 at 1 year (p<0.02).
When patients who were operated on were compared with their control subjects, improvement in OD1 and ODI1o failed to reach statistical significance either at the 3-or 12-month assessment. However, the patients who underwent surgery had postoperatively statistically significantly lower ODl4s at 1 year in comparison to initial assessment (median OD14, 14 vs 45; p<0.01).
Clinical Monitoring
Subjective symptoms were evaluated at 3-and 12-month visits. In the questionnaire, a change of at least two value points was regarded as significant. When patients receiving N-CPAP were compared with their control subjects, the improvement in excessive daytime somnolence reached statistical significance at 12 months (p<0.01) by means of the visual analog scales method, and also when assessed with the question, "Have you felt like falling asleep during the day when not in bed during the last 3 months?" (p<0.05). The patients who had been operated on were significantly less somnolent than their control subjects both at 3 (p<O.OO1) and 12 months (p<0.05) when evaluated with the visual analog scale (Tables 2 and 3 ). In the questionnaire, reported somnolence symptoms were significantly less for surgically treated patients at 3-month (p<0.01) and 12-month (p<0.05) visits. Reported snoring disappeared or diminished only moderately in the patients receiving N-CPAP. At 1 year, the surgically treated patients had benefited from the operation in regards to snoring, 40% reported less frequent snoring, and 75% reported less disturbing snoring. Four patients who had been randomized to conservative management either had to be placed on a regimen of N-CPAP (n= 1) or had to be operated on (n=3) during the study period because of their worsening symptoms, particularly their tendency to fall asleep while driving. Five patients refused to come to the follow-up visits because of moving to another place or some other personal reasons. They all were known to be alive at the end of the study.
DISCUSSION
This study was planned to compare the therapeutic effect of N-CPAP and surgery (UPPP with or without mandibular osteotomy) with conservative management in the treatment of OSAS. To our knowledge, only one randomized study about the effects of N-CPAP has been published before our study. Our results are in concordance with those earlier results.16 However, we believe that our study is the first randomized trial about the effects of upper airway surgery in the treatment of OSAS.
We were slow in recruiting, because many patients were not willing to be randomized. Our study population, however, did not differ significantly regarding the severity of OSAS or other patient characteristics from those not participating. Thus, our study is not biased in this respect.
The diagnosis of OSAS at our hospital is based on polygraphy using the static-charge-sensitive bed method, oximetry, and thermistors for monitoring ventilation. This method has been validated previously. '13"4 In a previous study, Douglas et desaturations. Furthermore, patients with obstructive pulmonary disease were excluded. All patients who used the CPAP machine regularly had an OD14 within the normal range. If we consider those 13 patients of the 21 who used the CPAP regularly as treatment successes, acceptability ofCPAP was 62% (13/21). One of 23 patients in the conservatively treated group had an OD14 within the normal range at 1 year.
Thirty-eight percent of the patients randomized to CPAP did not even start the therapy or used CPAP less than 4 h per night. This finding confirms the results of Hoffstein et al18 that most patients use N-CPAP only part of the night and not always every night. Furthermore, in accordance with prior studies, our noncompliant patients had no specific pretreatment characteristics that would have predicted poor compliance.18"9 Because excessive daytime somnolence has been reported to decrease rapidly after starting CPAP treatment,20 it is possible that our patients did not apply N-CPAP for long enough periods to ensure maximal subjective benefit.
Most ofour surgical patients underwent UPPP only. If an OD14 value in normal range, ie, <10 and not merely a reduction in that index, is considered to indicate long-term success following treatment of OSAS, only one third of our patients were successes after operative treatment. This is despite the fact that prior to selection of the treatment, we applied all the criteria suggested by Fujita7 and Powell et al8 for evaluation of operative suitability. Our results, however, are in accordance with other studies reporting follow-up after UPPP.21 Furthermore, the therapeutic effect of UPPP at 1 year may even lead to an excessively optimistic view of the longer-term results. 22 The patients in this study who were treated operatively showed definite improvement in daytime somnolence despite insufficient improvement of ODL, or ODI,o. The fact that subjective symptoms improve more than do objective polygraphic findings following UPPP has been documented also by other studies.23
Theoretically, this might indicate that threshold for arousal diminishes. Such a situation might lead to more severe and prolonged apneas and thus to an increased frequency of cardiovascular complications. Following UPPP, all patients regardless of symptoms, should preferably have a repeated overnight recording and objective measurement of daytime sleepiness. Unfortunately, owing to financial reasons, we were not able to evaluate daytime sleepiness objectively, ie, with the multiple sleep latency test.
In this study, the complication rate following UPPP was low compared with that reported in the literature.9
This may be due to chance. The complications following mandibular osteotomy in our study may reflect initial methodologic obstacles that lessened the surgeon's eagerness.
In conclusion, N-CPAP is effective in the treatment of OSAS, but suboptimal compliance is a problem. UPPP with or without mandibular osteotomy in the treatment of OSAS has a poor success rate even in well-preselected patients. Long-term follow-up studies regarding different treatment regimens are still needed.
